Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim A Reiss

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
JNCI Cancer Spectrum|March 18, 2021
Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic <i>ATM</i> AlterationsZain Hannan, Shun Yu, Susan Domchek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Immune Therapy in GI Malignancies: A ReviewJudy Wang, Kim A Reiss, Rina Khatri, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 2, 2025
Treatment Innovations in Pancreatic Cancer: Putting Patient Priorities FirstKim A Reiss, Kevin C Soares, Robert J Torphy, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 16, 2016
Growing Pains: a Simulation-Based Curriculum for Improving the Transition to Hematology/Oncology FellowshipKim A Reiss, Deepa Rangachari, David Cosgrove, et al.
Molecular Cancer Therapeutics|August 9, 2024
KRAS-Driven Tumorigenesis and KRAS-Driven Therapy in Pancreatic AdenocarcinomaMinh T Than, Mark O'Hara, Ben Z Stanger, et al.
The Oncologist|October 10, 2013
What lies within: novel strategies in immunotherapy for non-small cell lung cancerPatrick M Forde, Kim A Reiss, Amer M Zeidan, et al.
AIDS (London, England)|October 29, 2010
Raltegravir-induced cerebellar ataxiaKim A Reiss, Justin R Bailey, Paul A Pham, et al.
Open Forum Infectious Diseases|March 8, 2016
Immune Control Despite Protracted Lymphopenia After Chemoradiation in an Elite ControllerKim A Reiss, Dvone C Jackson, Anna Piotrowski, et al.
JCO Precision Oncology|February 9, 2022
Retrospective Survival Analysis of Patients With Advanced Pancreatic Ductal Adenocarcinoma and Germline <i>BRCA</i> or <i>PALB2</i> MutationsKim A Reiss, Shun Yu, Renae Judy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 5, 2021
Cost-Effectiveness of a Risk-Tailored Pancreatic Cancer Early Detection Strategy Among Patients With New-Onset DiabetesLouise Wang, Frank I Scott, Ben Boursi, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
JNCI Cancer Spectrum|March 18, 2021
Clinical Characteristics of Patients With Pancreatic Cancer and Pathogenic <i>ATM</i> AlterationsZain Hannan, Shun Yu, Susan Domchek, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2015
Immune Therapy in GI Malignancies: A ReviewJudy Wang, Kim A Reiss, Rina Khatri, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 2, 2025
Treatment Innovations in Pancreatic Cancer: Putting Patient Priorities FirstKim A Reiss, Kevin C Soares, Robert J Torphy, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|January 16, 2016
Growing Pains: a Simulation-Based Curriculum for Improving the Transition to Hematology/Oncology FellowshipKim A Reiss, Deepa Rangachari, David Cosgrove, et al.
Molecular Cancer Therapeutics|August 9, 2024
KRAS-Driven Tumorigenesis and KRAS-Driven Therapy in Pancreatic AdenocarcinomaMinh T Than, Mark O'Hara, Ben Z Stanger, et al.
The Oncologist|October 10, 2013
What lies within: novel strategies in immunotherapy for non-small cell lung cancerPatrick M Forde, Kim A Reiss, Amer M Zeidan, et al.
AIDS (London, England)|October 29, 2010
Raltegravir-induced cerebellar ataxiaKim A Reiss, Justin R Bailey, Paul A Pham, et al.
Open Forum Infectious Diseases|March 8, 2016
Immune Control Despite Protracted Lymphopenia After Chemoradiation in an Elite ControllerKim A Reiss, Dvone C Jackson, Anna Piotrowski, et al.
JCO Precision Oncology|February 9, 2022
Retrospective Survival Analysis of Patients With Advanced Pancreatic Ductal Adenocarcinoma and Germline <i>BRCA</i> or <i>PALB2</i> MutationsKim A Reiss, Shun Yu, Renae Judy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 5, 2021
Cost-Effectiveness of a Risk-Tailored Pancreatic Cancer Early Detection Strategy Among Patients With New-Onset DiabetesLouise Wang, Frank I Scott, Ben Boursi, et al.
Pageof 7